dc.date.accessioned | 2015-05-05T18:13:20Z | en |
dc.date.available | 2015-05-05T18:13:20Z | en |
dc.date.created | 1983-04-16 | en |
dc.date.issued | 1983-04-16 | en |
dc.identifier.bibliographicCitation | BMJ (British Medical Journal). 1983 Apr 16; 286(6373):
1295-1297. | en |
dc.identifier.issn | 0959-8138 | en |
dc.identifier.uri | http://worldcatlibraries.org/registry/gateway?version=1.0&url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&atitle=Code+of+Practice+for+the+Clinical+Assessment+of+Licensed+Medicinal+products+in+General+Practice&title=BMJ+&volume=286&issue=6373&pages=1295-1297&date=1983&au= | en |
dc.identifier.uri | http://hdl.handle.net/10822/724030 | en |
dc.description.abstract | A code of practice for the clinical assessment of licensed drugs by
physicians in general practice has been developed jointly by the British
Medical Association, the Royal Society of General Practitioners, and the
Association of the British Pharmaceutical Industry. The new code, reproduced
in full here, outlines the reasons drug assessments outside hospitals are
needed; defines the roles of pharmaceutical firms, ethics committees, and
investigators; lists items that must be included in research protocols; and
offers guidelines on confidentiality, publication of results, and
remuneration. (KIE abstract) | en |
dc.format | Article | en |
dc.language | en | en |
dc.publisher | British Medical Association; Royal College of General Practitioners; Association of the British Pharmaceutical Industry | en |
dc.source | BRL:KIE/15919 | en |
dc.subject | Clinical Ethics | en |
dc.subject | Clinical Ethics Committees | en |
dc.subject | Codes of Ethics | en |
dc.subject | Confidentiality | en |
dc.subject | Drug Industry | en |
dc.subject | Drugs | en |
dc.subject | Ethical Review | en |
dc.subject | Ethics | en |
dc.subject | Ethics Committees | en |
dc.subject | Guidelines | en |
dc.subject | General Practice | en |
dc.subject | Hospitals | en |
dc.subject | Human Experimentation | en |
dc.subject | Industry | en |
dc.subject | Investigators | en |
dc.subject | Patient Care | en |
dc.subject | Physicians | en |
dc.subject | Pharmaceutical Industry | en |
dc.subject | Remuneration | en |
dc.subject | Research | en |
dc.subject | Research Ethics | en |
dc.subject | Review | en |
dc.subject | Standards | en |
dc.title | Code of Practice for the Clinical Assessment of Licensed Medicinal Products in General Practice | en |
dc.provenance | Digital citation created by the National Reference Center for Bioethics Literature at Georgetown University for the BIOETHICSLINE database, part of the Kennedy Institute of Ethics' Bioethics Information Retrieval Project funded by the United States National Library of Medicine. | en |
dc.provenance | Digital citation migrated from OpenText LiveLink Discovery Server database named NBIO hosted by the Bioethics Research Library to the DSpace collection BioethicsLine hosted by Georgetown University. | en |